OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.890
-0.020 (-0.41%)
Nov 16, 2026, 4:00 PM EST - Market closed

OmniAb Revenue

OmniAb had revenue of $3.99M in the quarter ending September 30, 2026, with 78.34% growth. This brings the company's total for the last twelve months to $40.21M, up 90.63% year-over-year. In the year 2025, OmniAb had annual revenue of $18.67M, down -29.27%. That makes OmniAb the 29,525th largest company in the world by revenue and 3,927th in the United States.

Revenue (ttm)
$40.21M
Revenue Growth
+90.63%
P/S Ratio
17.74
Revenue / Employee
$451,809
Employees
89
Market Cap
713.26M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202518.67M-7.73M-29.27%
Dec 31, 202426.39M-7.77M-22.75%
Dec 31, 202334.16M-24.91M-42.17%
Dec 31, 202259.08M24.33M70.02%
Dec 31, 202134.75M11.48M49.34%
Dec 31, 202023.27M4.95M27.02%
Dec 31, 201918.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Apnimed108.80M
Janux Therapeutics23.29M
Alumis7.24M
Prime Medicine7.06M
Inventiva2.81M
Attovia Therapeutics1.44M
Revenue Rankings